![]() |
“But we could only achieve that once,” he says. “Once you’ve used it
up, you’re done. You then have to focus in on what happens at older
ages. At the older ages, it’s no longer diphtheria and tuberculosis.
You’ve got aging. You can treat diphtheria and tuberculosis. You can’t
treat aging—yet.”
As we grow older, our bodies change. Our skin wrinkles, our backs
stoop, our brains fill with plaque, and our blood vessels stiffen.
Changes take place within our cells as well, including damage from
environmental toxins and oxygen free radicals, the shortening of
telomeres (the tips of chromosomes) as cells divide, and other things
that scientists still don’t fully understand. All these changes raise
our odds of dying, if not of one disease, then of another. Those odds
double every seven years or so. That pace is the same from one culture
to the next, Olshansky and his colleagues have found, and from one
period of history to another. “No matter where we looked, it’s the
same,” he says. Aging, in other words, is deeply etched in our biology.
In fact, the same pattern turned up when Olshansky looked at other
species. Dogs, for example, live only 10 years on average. But if you
draw a dog curve and a human curve on the same scale, they are
practically identical.
While the odds of dying have dropped dramatically for babies, they have
dropped far less for the elderly. The maximum life span of humans has
barely budged over the decades, even as the average life expectancy has
soared. Simply attacking this or that disease won’t extend the human
life span any further, says Olshansky. “Eliminating cancer would only
get about three and a half extra years,” he says. If tomorrow no one
ever died of a heart attack again, three years. In fact, the mortality
curve suggests that ordinary medical advances would be unlikely to push
the average life span of Americans past 85 years. A tiny fraction will
live beyond 100.
In the seven years since the bet, obesity has exploded into a
nationwide epidemic. Obesity can lead to heart disease, diabetes, and
other potentially fatal disorders. Olshansky and his colleagues have
built demographic models to project the effect obesity will have on the
average life expectancy in the United States. The picture is grim.
“We’re losing between two and five years within the next 50 years,” he
says, “which is huge.”
Steven Austad, now 60 years old, still has the stocky body of a college
wrestler, and there are creases on his face from field seasons in the
sun. Although the malaria he contracted in Papua New Guinea still
flares up, he rarely finds himself in the jungle these days. He has
traded traps and radio collars for microscopes and centrifuges. In
fact, he has brought the field to his lab near San Antonio: There’s a
colony of naked mole rats in the basement. He and his colleague are now
searching for the molecular differences between species that die young
and others that live long.
In the years since the bet, Austad has grown even more certain that
he’s right. Scientists now have a much more detailed understanding of
how shutting down certain genes and restricting calories slow aging.
Scientist Edward Masoro, at the University of Texas, pioneered research
in the 1990s that showed that calorie restriction in animals leads to a
longer, healthier life span. It turns out that a low-calorie diet
switches on a key gene called SIRT1, which controls a network of dozens
of other genes. They create an army of proteins that protect a cell
from damage. Related versions of SIRT1 trigger the same response in
mammals, insects, and even yeast. Scientists in laboratories across the
country were performing similar experiments on spiders, mice, and
worms. For example, researchers at the University of California shut
down a gene called daf-2 in a microscopic worm known as
Caenorhabditis elegans and
it lived twice as long. The scientists weren’t sure what daf-2 actually
did, but the results were undeniable. Researchers at Brown University
found that manipulating a gene known as IGF-1 had a similar effect on
flies.
Discovering genes like SIRT1, daf-2, and IGF-1 opens up a new way to
fight aging. After all, human biology isn’t all that different from the
biology of mice or worms. We share many genes, such as daf-2, and they
do similar things for us. So if scientists are already figuring out how
to slow aging in animals, it might be possible to do the same for
people. Instead of going hungry for the rest of your life, you might be
able to take a pill containing molecules that are able to switch on
SIRT1 in your cells. In recent years, scientists have launched a
large-scale search for those molecules. One molecule that switches on
SIRT1, known as resveratrol, is produced by grapes and other plants.
Harvard University’s David Sinclair, PhD, and his colleagues have found
that, as predicted, resveratrol shows signs of slowing aging. They
fed resveratrol to 1-year-old mice that ate a high-fat diet that would
normally cause them to drop dead after about a year. But with regular
doses of resveratrol, the badly fed mice enjoyed a mortality rate as
low as mice on a normal diet—three years.